相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition
Manuel Scimeca et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Tumor Neurobiology and the War of Nerves in Cancer
Sam Faulkner et al.
CANCER DISCOVERY (2019)
The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
Peder R. Braadland et al.
MOLECULAR CANCER RESEARCH (2019)
Prostate Stem Cells and Cancer Stem Cells
Jia J. Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Role of the androgen receptor in urothelial cancer
Satoshi Inoue et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair H. Davies et al.
NATURE REVIEWS UROLOGY (2018)
TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways
Chao Liang et al.
CELL DEATH & DISEASE (2018)
Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage
Jung Wook Park et al.
SCIENCE (2018)
Cell subpopulation deconvolution reveals breast cancer heterogeneity based on DNA methylation signature
Yanhua Wen et al.
BRIEFINGS IN BIOINFORMATICS (2017)
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology
Steven M. Walker et al.
EUROPEAN UROLOGY (2017)
Adrenergic nerves activate an angio-metabolic switch in prostate cancer
Ali H. Zahalka et al.
SCIENCE (2017)
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
Shuang G. Zhao et al.
JAMA ONCOLOGY (2017)
Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome
Sungyong You et al.
CANCER RESEARCH (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
A basal stem cell signature identifies aggressive prostate cancer phenotypes
Bryan A. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
SPOP mutation leads to genomic instability in prostate cancer
Gunther Boysen et al.
ELIFE (2015)
Sympathetic nervous system regulation of the tumour microenvironment
Steven W. Cole et al.
NATURE REVIEWS CANCER (2015)
Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy
Alvaro Aytes et al.
CANCER CELL (2014)
High-risk prostate cancer-classification and therapy
Albert J. Chang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Adult Murine Prostate Basal and Luminal Cells Are Self-Sustained Lineages that Can Both Serve as Targets for Prostate Cancer Initiation
Nahyun Choi et al.
CANCER CELL (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Changmeng Cai et al.
CANCER RESEARCH (2011)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Identification of a Cell of Origin for Human Prostate Cancer
Andrew S. Goldstein et al.
SCIENCE (2010)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
A luminal epithelial stem cell that is a cell of origin for prostate cancer
Xi Wang et al.
NATURE (2009)
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
Sunita R. Setlur et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Transcriptomes of human prostate cells
Asa J. Oudes et al.
BMC GENOMICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular alterations in primary prostate cancer after androgen ablation therapy
CJM Best et al.
CLINICAL CANCER RESEARCH (2005)
Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines
N Dizeyi et al.
EUROPEAN UROLOGY (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)